The Global Commission is proud to announce the release of its 2024 end of year report, “From Idea to Action: Resource Compendium for Accelerating Rare Disease Diagnosis.” This report offers
In the pursuit of accelerating the diagnosis of rare diseases for children, DxGPT emerges as a transformative tool. Launched by in 2022, DxGPT builds on the success of its predecessor,
In the quest to provide timely and accurate care for children with rare diseases, the digital platform Unlocking Treatment Options Personalized In-Time Access (UTOPIA) stands out as a beacon of
The Global Commission to End the Diagnostic Odyssey for Children with a Rare Disease is an association composed of a diverse group of organizations and individuals committed to shortening the time for an accurate diagnosis for all children with rare diseases. The views expressed herein are solely those of the Commission and do not represent any individual, co-chair, or member organization’s views or opinions.
